Trial-based Cost-effectiveness Analysis of an Immediate Postoperative Mitomycin C Instillation in Patients with Non–muscle-invasive Bladder Cancer

BACKGROUND: Bladder cancer imposes a significant public health burden on the European Union. There is a need for cost-effective treatment and follow-up regimens. OBJECTIVE: To assess the cost-effectiveness of immediate mitomycin C (MMC) instillation within 1 d after surgery compared to delayed MMC i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hentschel, Anouk E., Blankvoort, Christian J., Bosschieter, Judith, Vis, André N., van Moorselaar, R. Jeroen A., Bosmans, Judith E., Nieuwenhuijzen, Jakko A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Bladder Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883187/
https://www.ncbi.nlm.nih.gov/pubmed/35243387
http://dx.doi.org/10.1016/j.euros.2021.12.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883187/
https://www.ncbi.nlm.nih.gov/pubmed/35243387
http://dx.doi.org/10.1016/j.euros.2021.12.008

Ejemplares similares